Melodiol Global Health (ASX:ME1)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Melodiol Global Health.
RELATED STOCKHEAD STORIES
Market Highlights: Tesla, Alphabet slump after posting results, and 5 ASX small caps to watch today
Rise and Shine: Everything you need to know before the ASX opens
Closing Bell: Tuesday wins what Monday lost on the ASX
ASX Small Caps Lunch Wrap: Who didn’t think this new format through properly this week?
Top 10 at 11: A Canadian land sale and gold, gold, gold are today’s news
ASX Small Caps Lunch Wrap: Who called the cops to back out of an online romance last week?
ASX Health Stocks: Island to tackle deadly Ebola virus
Closing Bell: ASX edges lower, but uranium miners rally on Dutton’s nuclear plants pledge
Property valued at up to $12m as Melodiol secures convertible note deal
‘Stable, material revenue generating business:’ Melodiol’s Canadian subsidiary maintains strong progress
Hot Money Monday: Why the Price Sales Ratio outshines the P/E ratio for comparing early-stage stocks
Closing Bell: ASX fleeced as retail stocks plunge; Alliance Nickel soars on great big grant
Melodiol’s Mernova thriving in Canada with solid start to quarter, expanded product reach
